American Research & Management Co. Vertex Pharmaceuticals Inc Transaction History

American Research & Management Co.

$362 Million
Q3 2022

A detailed history of American Research & Management Co. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, American Research & Management Co. holds 9,312 shares of VRTX stock, worth $4.68 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

9,312

Previous 9,312 -0.0%

Holding current value

$4.68 Million

Previous $2.62 Million 2.74%

% of portfolio

0.74%

Previous 0.67%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$234.96 - $292.55 $51,221 - $63,775	-218 Reduced 2.29%	9,312 $2.62 Million
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $4,428 - $5,219	20 Added 0.21%	9,530 $2.49 Million
Q4 2021 Jan 28, 2022	BUY	$177.01 - $223.45 $13,275 - $16,758	75 Added 0.79%	9,510 $2.09 Million
Q3 2021 Oct 28, 2021	BUY	$181.39 - $202.99 $10,883 - $12,179	60 Added 0.64%	9,435 $1.71 Million
Q2 2021 Jul 16, 2021	SELL	$187.49 - $221.1 $93,745 - $110,550	-500 Reduced 5.06%	9,375 $1.89 Million
Q1 2021 Apr 06, 2021	SELL	$207.02 - $241.31 $2,691 - $3,137	-13 Reduced 0.13%	9,875 $2.12 Million
Q4 2020 Jan 28, 2021	BUY	$207.01 - $276.09 $2.05 Million - $2.73 Million	9,888 New	9,888 $2.34 Million
Q3 2020 Oct 29, 2020	SELL	$255.65 - $303.1 $2.53 Million - $3 Million	-9,888 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$225.48 - $295.8 $2,931 - $3,845	13 Added 0.13%	9,888 $2.87 Million
Q1 2020 Apr 28, 2020	SELL	$199.77 - $247.81 $104,879 - $130,100	-525 Reduced 5.05%	9,875 $2.35 Million
Q3 2019 Oct 31, 2019	SELL	$166.23 - $187.09 $99,738 - $112,254	-600 Reduced 5.45%	10,400 $1.76 Million
Q2 2019 Jul 18, 2019	SELL	$164.61 - $190.37 $32,922 - $38,074	-200 Reduced 1.79%	11,000 $2.02 Million
Q3 2018 Oct 04, 2018	BUY	$167.73 - $192.74 $16,773 - $19,274	100 Added 0.9%	11,200 $2.16 Million
Q2 2018 Jul 25, 2018	BUY	$145.72 - $169.96 $291,440 - $339,920	2,000 Added 21.98%	11,100 $1.89 Million
Q1 2018 Apr 19, 2018	BUY	$151.6 - $177.13 $30,320 - $35,426	200 Added 2.25%	9,100 $1.48 Million
Q4 2017 Feb 08, 2018	SELL	$137.28 - $155.55 $6,864 - $7,777	-50 Reduced 0.56%	8,900 $1.33 Million
Q3 2017 Oct 17, 2017	BUY	$148.13 - $162.24 $1.33 Million - $1.45 Million	8,950	8,950 $1.36 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.

Account

American Research & Management Co. Vertex Pharmaceuticals Inc Transaction History